Robert Hallowell, MD
Director, Interstitial Lung Disease (ILD) Program
Director, Pulmonary Ambulatory Practice
Assistant Professor of Medicine
Academic Interests
Anti-synthetase Syndrome, Connective Tissue Disease-Associated ILD, Myositis-associated ILD, Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis (IPF).
Awards and Recognition
Harvard Pulmonary and Critical Care Fellowship Teacher of the Year
More information can be found on Dr. Hallowell's Harvard Catalyst Profile.
+Current Projects
My research centers on factors that influence outcomes in interstitial lung disease (ILD), including pulmonary fibrosis. Leveraging a large ILD database that spans the Harvard-affiliated hospitals, I study how autoantibody profiles shape disease phenotypes with the goal of refining treatment algorithms. This work has fostered collaborations across Radiology, Pathology, Rheumatology, and other disciplines. In parallel, I serve as an investigator on several pulmonary-fibrosis clinical trials.